Giulio Marchesini; Elisabetta Bugianesi; Patrizia Burra; Fabio Marra; Luca Miele; Anna Alisi; Piero Vajro; Mario Masarone; Salvatore Petta; Marcello Persico; Gianluca Svegliati-Baroni; Luca Valenti; Massimo Federici; Francesco Purrello; Ferdinando Carlo Sasso; Giovanni Targher; Luca Busetto; Maria Letizia Petroni; Ferruccio Santini; Calogero Cammà; Agostino Colli

Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines

Medicine 95(5) (2016)

Raika Jamali; Abbas Arj; Mohsen Razavizade; Mohammad Hossein Aarabi

Pharmacological interventions for non-alcohol related fatty liver disease (NAFLD)

Cochrane Database of Systematic Reviews 2017(4) (2017)

Rosa Lombardi; Simona Onali; Douglas Thorburn; Brian R Davidson; Kurinchi Selvan Gurusamy; Emmanuel Tsochatzis

Diabetes drugs for nonalcoholic fatty liver disease: a systematic review

Systematic Reviews 8(1) (2019)

Ian Blazina; Shelley Selph

Mechanism of action and effect of immune-modulating agents in the treatment of psoriasis

Biomedicine & Pharmacotherapy 85 (2017)

Rehab M. El-Gharabawy; Amira S. Ahmed; Amal H. Al-Najjar

Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease

World Journal of Gastroenterology 22(21) (2016)

Raika Jamali; Mohsen Razavizade; Abbas Arj; Mohammad Hossein Aarabi

Cardiovascular protective effects of PPARγ agonists in hypothyroid rats: protection against oxidative stress

Clinical and Experimental Hypertension 44(6) (2022)

Yousef Baghcheghi; Farimah Beheshti; Mahmoud Hosseini; Arezoo Gowhari-Shabgah; Mohammad Ali-Hassanzadeh; Mahdiyeh Hedayati-Moghadam

The effect of pioglitazone on weight, lipid profile and liver enzymes in type 2 diabetic patients

Therapeutic Advances in Endocrinology and Metabolism 6(2) (2015)

Nasser Aghamohammadzadeh; Mitra Niafar; Elham Dalir Abdolahinia; Farzad Najafipour; Saeed Mohamadzadeh Gharebaghi; Khadijeh Adabi; Elaheh Dalir Abdolahinia; Hamidreza Ahadi

The Effects of Helicobacter Pylori Eradication on Liver Function and Metabolic Profile in Non-diabetic Non-alcoholic Steatohepatitis: A 5-year Randomized Clinical Trial

Middle East Journal of Digestive Diseases 14(1) (2022)

Arsia Jamali; Shahrokh Karbalai; Ghazale Tefagh; Raika Jamali; Ayat Ahmadi

Research Progress of the Prevention and Treatment of Metabolic Associated Fatty Liver Disease as a Complication Disease of Endocrine Therapy for Breast Cancer

Advances in Clinical Medicine 15(03) (2025)

胜鹏覃

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Digestive and Liver Disease 54(2) (2022)

Data on Adiponectin from 2010 to 2020: Therapeutic Target and Prognostic Factor for Liver Diseases?

International Journal of Molecular Sciences 21(15) (2020)

Misaq Heydari; María Eugenia Cornide-Petronio; Mónica B. Jiménez-Castro; Carmen Peralta

Protein analysis of rat hepatocytes under conditions glutamate-induced obesity and its correction

Bulletin of Taras Shevchenko National University of Kyiv. Series: Biology 70(2) (2015)

D. Voieikova; L. Stepanova; O. Savchuk; L. Ostapchenko; M. Kondro

The impact of metformin on weight and metabolic parameters in patients with obesity: A systematic review and meta‐analysis of randomized controlled trials

Diabetes, Obesity and Metabolism 26(5) (2024)

Rachelle Haber; Fatima Zarzour; Malak Ghezzawi; Natalie Saadeh; Dania S. Bacha; Lama Al Jebbawi; Marlene Chakhtoura; Christos S. Mantzoros

Levocetirizine ameliorates high fructose diet-induced insulin resistance, vascular dysfunction and hepatic steatosis in rats

European Journal of Pharmacology 740 (2014)

Noha M. Shawky; George S.G. Shehatou; Mona Abdel Rahim; Ghada M. Suddek; Nariman M. Gameil

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis

Acta Diabetologica 59(4) (2022)

Chen Ding; Yaxin Tang; Wenqiang Zhu; Piaopiao Huang; Pingan Lian; Juanli Ran; Xiansheng Huang

How Does Addition of Regular Aerobic Exercises, Influence the Efficacy of Calorie-Restricted Diet in Patients with Non-Alcoholic Steatohepatatis (NASH)?

Hepatitis Monthly 17(5) (2017)

Hossein Nikroo; Mohsen Nematy; Seyyed Reza Attarzadeh Hosseini; Hamid Reza Sima; Farkhonde Razmpour

Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review

Frontiers in Endocrinology 12 (2021)

Yuqi Liu; Juan Li; Zhe Yan; Dan Liu; Jinfang Ma; Nanwei Tong

Optimized strategy among diet, exercise, and pharmacological interventions for nonalcoholic fatty liver disease: A network meta‐analysis of randomized controlled trials

Obesity Reviews 25(6) (2024)

Hao Wang; Qianqian Ma; Youpeng Chen; Ling Luo; Junzhao Ye; Bihui Zhong

The effects of pioglitazone and rosiglitazone on liver function in hypothyroid rats

Journal of Complementary and Integrative Medicine 21(1) (2024)

Yousef Baghcheghi; Farimah Beheshti; Fatemeh Seyedi; Mahdiyeh Hedayati-Moghadam; Hedyeh Askarpour; Aliasghar Kheirkhah; Ahmad Golkar; Mohammad Dalfardi; Mahmoud Hosseini

Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis

World Journal of Diabetes 12(9) (2021)

Yi-Zhou Huang; Gang-Yi Yang; Cong Wang; Xing-Yu Chen; Li-Li Zhang

Potential Approaches to Ameliorate Hepatic Fat Accumulation Seen with MTP Inhibition

Drug Safety 37(4) (2014)

Minjie Lin; Shuiping Zhao; Li Shen; Danyan Xu

The Effect of Berberis Vulgaris Extract on Transaminase Activities in Non-Alcoholic Fatty Liver Disease

Hepatitis Monthly 15(2) (2015)

Raziye Iloon Kashkooli; Seyed Saeed Najafi; Farkhondeh Sharif; Azadeh Hamedi; Mohammad Kazem Hoseini Asl; Majid Najafi Kalyani; Mehdi Birjandi

Dietary Determinants of Non-Alcoholic Fatty Liver Disease in Lean and Non-Lean Adult Patients: A Population-Based Study in Shiraz, Southern Iran

Hepatitis Monthly 17(4) (2017)

Behnam Honarvar; Kamran Bagheri Lankarani; Parisa Keshani; Tayebe Rafiee

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review

European Journal of Clinical Pharmacology 80(1) (2024)

Maria Zachou; Pagona Flevari; Narjes Nasiri-Ansari; Constantinos Varytimiadis; Evangelos Kalaitzakis; Eva Kassi; Theodoros Androutsakos

Efficacy of Various Hypoglycemic Agents in the Treatment of Patients With Nonalcoholic Liver Disease With or Without Diabetes： A Network Meta-Analysis

Frontiers in Endocrinology 12 (2021)

Jingxuan Lian; Jianfang Fu

Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats

Dubai Medical Journal 3(2) (2020)

Mahmoud M. Farag; Ehab H. Ashour; Wessam F. El-Hadidy

Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?

Middle East Journal of Digestive Diseases 12(2) (2020)

Raika Jamali; Mehdi Ebrahimi; Ali Faryabi; Haleh Ashraf

Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)

Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity 27(5) (2021)

Modulation Effect of Peroxisome Proliferator-Activated Receptor Agonists on Lipid Droplet Proteins in Liver

Journal of Diabetes Research 2016 (2016)

Yun-Xia Zhu; Ming-Liang Zhang; Yuan Zhong; Chen Wang; Wei-Ping Jia

Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)

Hepatitis Monthly 18(2) (2018)

Zahra Dehnavi; Farkhonde Razmpour; Mahmoud Belghaisi Naseri; Mohsen Nematy; Seyed Ali Alamdaran; Hassan Ali Vatanparast; Mohsen Azimi Nezhad; Bita Abbasi; Azita Ganji